A New Dynamic

A New Dynamic With an eye toward host-pathogen interactions, can a Penn State center predict and prevent the next pandemic? By Brendan Borrell ARTICLE EXTRAS 1 "Our vision really is to have a systems approach to disease," says Hudson. "Issues that go from intracellular interactions between viruses and cells right the way through to pandemics, something we call the protein-to-pandemic link." Pathogens don't just interact, they evol

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

With an eye toward host-pathogen interactions, can a Penn State center predict and prevent the next pandemic?
By Brendan Borrell

ARTICLE EXTRAS

"Our vision really is to have a systems approach to disease," says Hudson. "Issues that go from intracellular interactions between viruses and cells right the way through to pandemics, something we call the protein-to-pandemic link."

Pathogens don't just interact, they evolve. In the 1960s, optimistic researchers had declared victory over infectious disease. It was time to move on to heart disease, cancer, and psychiatric disorders. That bubble burst in 1981 with the recognition of HIV. The disease had leapt from nonhuman primates to humans and continued to evolve and diversify in ways scientists still don't understand.

Bryan Grenfell began his career on this first wave of disappointment. He worked with Roy Anderson, an early pioneer of disease ecology at Imperial College London, to build mathematical models of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Brendan Borrell

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide